BURLINGTON, N.C., July 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Test Finder, a first-of-its ...

Access to rapidly developing diagnostic technology such as blood-based biomarkers for early detection and subsequent ...

BURLINGTON, N.C., July 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Test Finder, a first-of-its ...

The Food and Drug Administration has authorized the use of Labcorp's blood-based in-vitro diagnostic test that's works by detesting the amyloid plaques associated with the disease in certain patients.

By offering this FDA-cleared blood test nationwide, Labcorp is leading the way in delivering innovative solutions for Alzheimer's disease and other neurological conditions by helping patients ...